Act I — Fall & Fragmentation
Were “En-Fem-E No. 9 Reborn” a work of art or a fragrance, it would defy the sweet or the pretty. It would open with the sharpness of black pepper and broken glass (the pain of breaking down), a heart of orris root and rusted metal (memory and resilience), and a dry-down of ambergris, ozone, and heated skin (the scent of a soul that has walked through fire). It would be unisex in the truest sense—not androgynous, but post-gender: the feminine as a force, not a costume. En-Fem-E No. 9 Reborn
Visually, it might be a self-portrait where the figure is simultaneously dissolving into pixels and crystallizing into a new geometric form—a nod to the digital rebirth of the self in avatars, usernames, and curated identities. No. 9 is the iteration that finally feels right after eight drafts. Act I — Fall & Fragmentation Were “En-Fem-E No
En-Fem-E No. 9 Reborn is sold as a dietary supplement in the United States and many European countries. It is not FDA-approved for gender transition or any medical condition. It is legally sold under the DSHEA act (in the US), meaning the manufacturer is responsible for safety, but the claims are not evaluated by regulators. It would be unisex in the truest sense—not
Do not combine En-Fem-E No. 9 Reborn with synthetic hormones (estradiol valerate, spironolactone, cyproterone acetate, bicalutamide) without medical supervision. The additive estrogenic load could increase the risk of deep vein thrombosis (DVT), especially in smokers or those over 40.